| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.203 | 10.689 | 10.508 | 13.861 | 15.067 | 14.885 | 14.555 | 17.946 | 20.418 | 20.505 |
| Total Income - EUR | 15.203 | 10.689 | 10.508 | 13.861 | 15.067 | 14.885 | 14.555 | 17.946 | 20.418 | 20.505 |
| Total Expenses - EUR | 15.582 | 12.987 | 10.966 | 13.079 | 12.916 | 13.179 | 13.766 | 16.186 | 19.675 | 19.247 |
| Gross Profit/Loss - EUR | -378 | -2.298 | -459 | 782 | 2.151 | 1.706 | 788 | 1.760 | 744 | 1.258 |
| Net Profit/Loss - EUR | -834 | -2.622 | -774 | 366 | 1.699 | 1.564 | 631 | 1.608 | 570 | 729 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Prosit Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.332 | 265 |
| Current Assets | 3.155 | 1.334 | 1.754 | 2.467 | 3.076 | 2.417 | 2.935 | 4.692 | 4.975 | 5.883 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.350 | 668 | 657 | 645 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1.805 | 666 | 1.097 | 1.822 | 3.076 | 2.417 | 2.935 | 4.692 | 4.975 | 5.883 |
| Shareholders Funds | 7 | -2.615 | -3.345 | -2.917 | -1.162 | 425 | 1.047 | 2.658 | 3.220 | 3.931 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.148 | 3.949 | 5.098 | 5.384 | 4.237 | 1.992 | 1.888 | 2.035 | 3.087 | 2.216 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Prosit Med Srl